The biology of vascular endothelial growth factors

Cardiovascular Research

Volumn 65, Issue 3, 2005, Pages 550-563

  Tammela, Tuomas ^a   Enholm, Berndt ^a   Alitalo, Kari ^a   Paavonen, Karri ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Endothelial receptors; Growth factors; Lymphangiogenesis; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; NEUROPILIN 1; NEUROPILIN 2; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTERIOLE; ATHEROSCLEROTIC PLAQUE; BREAST METASTASIS; CANCER THERAPY; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; CHOLESTASIS; CLINICAL TRIAL; COLLATERAL CIRCULATION; DEVELOPMENT; DISEASE ASSOCIATION; DRUG INDICATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DISORDER; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; KIDNEY METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM TUMOR; LYMPHEDEMA; MILROY DISEASE; MISSENSE MUTATION; MOLECULAR BIOLOGY; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VASCULARIZATION; VASCULARIZATION; VISCERAL METASTASIS;

CARDIOVASCULAR DISEASES; HUMANS; LYMPHANGIOGENESIS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 12344274486     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.12.002     Document Type: Review

References (180)

1. A.L. Kolodkin, D.V. Levengood, E.G. Rowe, Y.T. Tai, R.J. Giger, and D.D. Ginty Neuropilin is a semaphorin III receptor Cell 90 1997 753 762
2. H. Chen, A. Chedotal, Z. He, C.S. Goodman, and M. Tessier-Lavigne Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III Neuron 19 1997 547 559
3. N. Ferrara, H.-P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
4. L.E. Benjamin, and E. Keshet Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal Proc. Natl. Acad. Sci. U. S. A. 94 1997 8761 8766
5. H.-P. Gerber, V. Dixit, and N. Ferrara Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells J. Biol. Chem. 273 1998 13313 13316
6. D.O. Bates, N.J. Hillman, B. Williams, C.R. Neal, and T.M. Pocock Regulation of microvascular permeability by vascular endothelial growth factors J. Anat. 200 2002 581 597
7. J.D. Hood, C.J. Meininger, M. Ziche, and H.J. Granger VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells Am. J. Physiol. 274 1998 H1054 H1058
8. J. Kroll, and J. Waltenberger A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells Biochem. Biophys. Res. Commun. 265 1999 636 699
9. E. Storkebaum, D. Lambrechts, and P. Carmeliet VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection BioEssays 26 2004 943 954
10. M.S. Pepper, N. Ferrara, L. Orci, and R. Montesano Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem. Biophys. Res. Commun. 181 1991 902 906
11. E.N. Unemori, N. Ferrara, E.A. Bauer, and E.P. Amento Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells J. Cell. Physiol. 153 1992 557 562
12. S.J. Mandriota, G. Seghezzi, J.-D. Vassalli, N. Ferrara, S. Wasi, and R. Mazzieri Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J. Biol. Chem. 270 1995 9709 9716
13. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 25 2004 581 611
14. C.J. Robinson, and S.E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell. Sci. 114 2001 853 865
15. S. Hiratsuka, Y. Kataoka, K. Nakao, K. Nakamura, S. Morikawa, and S. Tanaka VEGF-A is involved in guidance of VEGF-receptor-positive cells to the anterior portion of early embryos Mol. Cell. Biol. 25 2005 355 363
16. B.M. Weinstein What guides early embryonic blood vessel formation? Dev. Dyn. 215 1999 2 11
17. P. Carmeliet, Y.S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, and I. Cornelissen Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat. Med. 5 1999 495 502
18. I. Stalmans, Y.S. Ng, R. Rohan, M. Fruttiger, A. Bouche, and A. Yuce Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms J. Clin. Invest. 109 2002 327 336
19. C.W. Pugh, and P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 2003 677 684
20. A. Luttun, K. Brusselmans, H. Fukao, M. Tjwa, S. Ueshima, and J.M. Herbert Loss of placental growth factor protects mice against vascular permeability in pathological conditions Biochem. Biophys. Res. Commun. 295 2002 428 434
21. V.A.J. Kempf, M. Lebiedziejewski, K. Alitalo, J.-H. Wälzlein, U. Ehehalt, and J. Fiebig Activation of HIF-1 in bacillary angiomatosis: evidence for a role of HIF-1 in bacterial infections Circ. Res. 3 2005 623 632
22. B. Oosthuyse, L. Moons, E. Storkebaum, H. Beck, D. Nuyens, and K. Brusselmans Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nat. Genet. 28 2001 131 138
23. Y.P. Xia, B. Li, D. Hylton, M. Detmar, G.D. Yancopoulos, and J.S. Rudge Transgenic delivery of VEGF to the mouse skin leads to an inflammatory condition resembling human psoriasis Blood 102 2003 161 168
24. F. Larcher, R. Murillas, M. Bolontrade, C.J. Conti, and J.L. Jorcano VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development Oncogene 17 1998 303 311
25. H. Rossiter, C. Barresi, J. Pammer, M. Rendl, J. Haigh, and E.F. Wagner Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation Cancer Res. 64 2004 3508 3516
26. L. Sepp-Lorenzino, E. Rands, X. Mao, B. Connolly, J. Shipman, and J. Antanavage A novel orally bioavailable inhibitor of kinase insert domain-containing receptor induces antiangiogenic effects and prevents tumor growth in vivo Cancer Res. 64 2004 751 756
27. F. Kabbinavar, H.I. Hurwitz, L. Fehrenbacher, N.J. Meropol, W.F. Novotny, and G. Lieberman Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J. Clin. Oncol. 21 2003 60 65 [comment]
28. N. Ferrara Role of vascular endothelial growth factor in physiological and pathological conditions: therapeutic implications Semin. Oncol. 29 2002 10 14
29. J.A. Nagy, E. Vasile, D. Feng, C. Sundberg, L.F. Brown, and M.J. Detmar Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis J. Exp. Med. 196 2002 1497 1506
30. A. Saaristo, T. Veikkola, B. Enholm, M. Hytonen, J. Arola, and K. Pajusola Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes FASEB J. 16 2002 1041 1049
31. H. Kubo, R. Cao, E. Brakenhielm, T. Makinen, Y. Cao, and K. Alitalo Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea Proc. Natl. Acad. Sci. U. S. A. 99 2002 8868 8873
32. T.T. Rissanen, J.E. Markkanen, M. Gruchala, T. Heikura, A. Puranen, and M.I. Kettunen VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Circ. Res. 92 2003 1098 1106
33. R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability Circ. Res. 94 2004 664 670
34. C.G. Lee, H. Link, P. Baluk, R.J. Homer, S. Chapoval, and V. Bhandari Vascular endothelial growth factor (VEGF) induces remodeling and enhances T(H)2-mediated sensitization and inflammation in the lung Nat. Med. 10 2004 1095 1103
35. M. Clauss, H. Weich, G. Breier, U. Knies, W. Rockl, and J. Waltenberger The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis J. Biol. Chem. 271 1996 17629 17634
36. S. Rafii, S. Avecilla, S. Shmelkov, K. Shido, R. Tejada, and M.A. Moore Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment Ann. N. Y. Acad. Sci. 996 2003 49 60
37. C. Cursiefen, L. Chen, L.P. Borges, D. Jackson, J. Cao, and C. Radziejewski VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J. Clin. Invest. 113 2004 1040 1050
38. M.J. Karkkainen, P. Haiko, K. Sainio, J. Partanen, J. Taipale, and T.V. Petrova Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Nat. Immunol. 5 2004 74 80
39. Persico MG, Vincenti V, DiPalma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). In: L. Claesson-Welsh editor. Vascular growth factors and angiogenesis. Springer-Verlag, Berlin: Springer-Verlag, MG Persico, V Vincenti, DiPalma T. 1999, p. 31-40.
40. M. Autiero, J. Waltenberger, D. Communi, A. Kranz, L. Moons, and D. Lambrechts Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat. Med. 9 2003 936 943
41. J.E. Park, H.H. Chen, J. Winer, K.A. Houck, and N. Ferrara Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR J. Biol. Chem. 269 1994 25646 25654
42. J.A. Nagy, A.M. Dvorak, and H.F. Dvorak VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis Trends Cardiovasc. Med. 13 2003 169 175
43. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, and M. De Mol Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 7 2001 575 583
44. T. Odorisio, C. Schietroma, M.L. Zaccaria, F. Cianfarani, C. Tiveron, and L. Tatangelo Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability J. Cell. Sci. 115 2002 2559 2567
45. H. Oura, J. Bertoncini, P. Velasco, L.F. Brown, P. Carmeliet, and M. Detmar A critical role of placental growth factor in the induction of inflammation and edema formation Blood 101 2003 560 567
46. P. Carmeliet VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6 2001 1102 1103
47. A. Luttun, M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, and F. Liao Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat. Med. 8 2002 831 840
48. F. Pipp, M. Heil, K. Issbrucker, T. Ziegelhoeffer, S. Martin, and J. van den Heuvel VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism Circ. Res. 92 2003 378 385
49. B. Olofsson, M. Jeltsch, U. Eriksson, and K. Alitalo Current biology of VEGF-B and VEGF-C Curr. Opin. Biotechnol. 10 1999 528 535
50. B. Olofsson, K. Pajusola, G. von Euler, D. Chilov, K. Alitalo, and U. Eriksson Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform J. Biol. Chem. 271 1996 19130 19317
51. B. Enholm, K. Paavonen, A. Ristimaki, V. Kumar, Y. Gunji, and J. Klefstrom Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia Oncogene 14 1997 2475 2483
52. P. Salven, A. Lymboussaki, P. Heikkila, H. Jaaskela-Saari, B. Enholm, and K. Aase Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors Am. J. Pathol. 153 1998 103 138
53. D. Bellomo, J.P. Headrick, G.U. Silins, C.A. Paterson, P.S. Thomas, and M. Gartside Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia Circ. Res. 86 2000 E29 E35 [Online]
54. K. Aase, G. von Euler, X. Li, A. Ponten, P. Thoren, and R. Cao Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect Circulation 104 2001 358 364
55. J.C. Wanstall, A. Gambino, T.K. Jeffery, M.M. Cahill, D. Bellomo, and N.K. Hayward Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension Cardiovasc. Res. 55 2002 361 368
56. V. Louzier, B. Raffestin, A. Leroux, D. Branellec, J.M. Caillaud, and M. Levame Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension Am. J. Physiol., Lung Cell. Mol. Physiol. 284 2003 L926 L937
57. A.W. Mould, I.D. Tonks, M.M. Cahill, A.R. Pettit, R. Thomas, and N.K. Hayward Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis Arthritis Rheum. 48 2003 2660 2669
58. J.S. Silvestre, R. Tamarat, T.G. Ebrahimian, A. Le-Roux, M. Clergue, and F. Emmanuel Vascular endothelial growth factor-B promotes in vivo angiogenesis Circ. Res. 93 2003 114 123
59. V. Joukov, T. Sorsa, V. Kumar, M. Jeltsch, L. Claesson-Welsh, and Y. Cao Proteolytic processing regulates receptor specificity and activity of VEGF-C EMBO J. 16 1997 3898 3911
60. G. Siegfried, A. Basak, J.A. Cromlish, S. Benjannet, J. Marcinkiewicz, and M. Chretien The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis J. Clin. Invest. 111 2003 1723 1732
61. P. Saharinen, T. Tammela, M.J. Karkkainen, and K. Alitalo Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation Trends Immunol. 25 2004 387 395
62. E. Kukk, A. Lymboussaki, S. Taira, A. Kaipainen, M. Jeltsch, and V. Joukov VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development Development 122 1996 3829 3837
63. A. Lymboussaki, B. Olofsson, U. Eriksson, and K. Alitalo Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia Circ. Res. 85 1999 992 999
64. S.J. Oh, M.M. Jeltsch, R. Birkenhager, J.E. McCarthy, H.A. Weich, and B. Christ VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane Dev. Biol. 188 1997 96 109
65. M. Jeltsch, A. Kaipainen, V. Joukov, X. Meng, M. Lakso, and H. Rauvala Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 276 1997 1423 1425
66. B. Enholm, T. Karpanen, M. Jeltsch, H. Kubo, F. Stenback, and R. Prevo Adenoviral expression of VEGF-C induces lymphangiogenesis in the skin Circ. Res. 88 2001 623 629
67. T. Veikkola, L. Jussila, T. Makinen, T. Karpanen, M. Jeltsch, and T.V. Petrova Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice EMBO J. 20 2001 1223 1231
68. A. Ristimaki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C J. Biol. Chem. 273 1998 8413 8418
69. D. Chilov, E. Kukk, S. Taira, M.M. Jeltsch, J. Kaukonen, and A. Palotie Genomic organization of human and mouse genes for vascular endothelial growth factor C J. Biol. Chem. 272 1997 25176 25183
70. J.L. Su, J.Y. Shih, M.L. Yen, Y.M. Jeng, C.C. Chang, and C.Y. Hsieh Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma Cancer Res. 64 2004 554 564
71. D. Kerjaschki, H.M. Regele, I. Moosberger, K. Nagy-Bojarski, B. Watschinger, and A. Soleiman Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates J. Am. Soc. Nephrol. 15 2004 603 612
72. K. Paavonen, J. Mandelin, T. Partanen, L. Jussila, T.-F. Li, and K. Alitalo Vascular endothelial growth factors -C and -D and their VEGFR-2 and -3 receptors in blood and lymphatic vessels in healthy and rheumatoid synovium J. Rheumatol. 29 2002 39 45
73. M. Skobe, T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, and P. Velasco Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat. Med. 7 2001 192 198
74. T. Karpanen, and K. Alitalo Lymphatic vessels as targets of tumor therapy? J. Exp. Med. 194 2001 F37 F42
75. S.J. Mandriota, L. Jussila, M. Jeltsch, A. Compagni, D. Baetens, and R. Prevo Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis EMBO J. 20 2001 672 682
76. T. Karpanen, M. Egeblad, M.J. Karkkainen, H. Kubo, S. Yla-Herttuala, and M. Jaattela Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth Cancer Res. 61 2001 1786 1790
77. Y. He, K. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-Herttuala, and T. Takahashi Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling J. Natl. Cancer Inst. 94 2002 819 825
78. Y. He, I. Rajantie, M. Ilmonen, T. Makinen, M.J. Karkkainen, and P. Haiko Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis Cancer Res. 64 2004 3737 3740
79. J.S. Reis-Filho, and F.C. Schmitt Lymphangiogenesis in tumors: what do we know? Microsc. Res. Tech. 60 2003 171 180
80. Y. He, T. Karpanen, and K. Alitalo Role of lymphangiogenic factors in tumor metastasis Biochim. Biophys. Acta 1654 2004 3 12
81. M.M. Vleugel, R. Bos, P. van der Groep, A.E. Greijer, A. Shvarts, and H.V. Stel Lack of lymphangiogenesis during breast carcinogenesis J. Clin. Pathol. 57 2004 746 751
82. M.E. Baldwin, B. Catimel, E.C. Nice, S. Roufail, N.E. Hall, and K.L. Stenvers The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man J. Biol. Chem. 276 2001 19166 19171
83. F. Farnebo, F. Piehl, and J. Lagercrantz Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embyonic lung Biochem. Biophys. Res. Commun. 257 1999 891 894
84. S.A. Stacker, C. Caesar, M.E. Baldwin, G.E. Thornton, R.A. Williams, and R. Prevo VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat. Med. 7 2001 186 191
85. M.G. Achen, R.A. Williams, M.P. Minekus, G.E. Thornton, K. Stenvers, and P.A. Rogers Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis J. Pathol. 193 2001 147 154
86. H. Ishii, T. Yazawa, H. Sato, T. Suzuki, M. Ikeda, and Y. Hayashi Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs) Lung Cancer 45 2004 325 337
87. T.V. Byzova, C.K. Goldman, J. Jankau, J. Chen, G. Cabrera, and M.G. Achen Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo Blood 99 2002 4434 4442
88. M. Shibuya, S. Yamaguchi, A. Yamane, T. Ikeda, A. Tojo, and H. Matsushime Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family Oncogene 5 1990 519 524
89. K. Huang, C. Andersson, G.M. Roomans, N. Ito, and L. Claesson-Welsh Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers Int. J. Biochem. Cell Biol. 33 2001 315 324
90. I. Zachary, and G. Gliki Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovasc. Res. 49 2001 568 581
91. H.P. Gerber, F. Conorelli, J. Park, and N. Ferrara Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia J. Biol. Chem. 272 1997 23659 23667
92. T.A. Partanen, K. Alitalo, and M. Miettinen Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors Cancer 86 1999 2406 2412
93. A. Kaipainen, J. Korhonen, K. Pajusola, O. Aprelikova, M.G. Persico, and B.I. Terman The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells J. Exp. Med. 178 1993 2077 2088
94. K.G. Peters, C. De Vries, and L.T. Williams Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth Proc. Natl. Acad. Sci. U. S. A. 90 1993 8915 8919
95. G.H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
96. S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice Proc. Natl. Acad. Sci. U. S. A. 4 1998 9349 9354
97. S. Hiratsuka, Y. Maru, A. Okada, M. Seiki, T. Noda, and M. Shibuya Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis Cancer Res. 61 2001 1207 1213
98. B. Barleon, S. Sozzani, D. Zhou, H.A. Weich, A. Mantovani, and D. Marme Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336 3343
99. P. Carmeliet, and A. Luttun The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis Thromb. Haemost. 86 2001 289 297
100. K. Hattori, B. Heissig, Y. Wu, S. Dias, R. Tejada, and B. Ferris Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment Nat. Med. 8 2002 841 849
101. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. See editorial J. Clin. Invest. 111 2003 649 658
102. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia New Engl. J. Med. 350 2004 672 683
103. W. Matthews, C.T. Jordan, M. Gavin, N.A. Jenkins, N.G. Copeland, and I.R. Lemischka A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoetic cells and exhibiting close genetic linkage to c-kit Proc. Natl. Acad. Sci. U. S. A. 88 1991 9026 9030
104. B.I. Terman, M.E. Carrion, E. Kovacs, B.A. Rasmussen, R.L. Eddy, and T.B. Shows Identification of a new endothelial cell growth factor receptor tyrosine kinase Oncogene 6 1991 1677 1683
105. M. Meyer, M. Clauss, A. Lepple-Wienhues, J. Waltenberger, H.G. Augustin, and M. Ziche A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases EMBO J. 18 1999 363 374
106. L.M. Wise, T. Veikkola, A.A. Mercer, L.J. Savory, S.B. Fleming, and C. Caesar The vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1 Proc. Natl. Acad. Sci. U. S. A. 96 1999 3071 3076
107. H. Gille, J. Kowalski, B. Li, J. LeCouter, B. Moffat, and T.F. Zioncheck Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants J. Biol. Chem. 276 2001 3222 3230
108. D.T. Shima, U. Deutsch, and P.A. D'Amore Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability FEBS Lett. 370 1995 203 208
109. T. Matsumoto, and L. Claesson-Welsh VEGF receptor signal transduction Science's STKE 112 2001 1 17
110. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, and M.L. Breitman Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
111. F. Shalaby, J. Ho, W.L. Stanford, K.D. Fischer, A.C. Schuh, and L. Schwartz A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis Cell 89 1997 981 990
112. F. Baffert, G. Thurston, M. Rochon-Duck, T. Le, R. Brekken, and D.M. McDonald Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels Circ. Res. 94 2004 984 992
113. 3 in the activation of vascular endothelial growth factor receptor-2 EMBO J. 18 1999 882 892
114. H. Hutchings, N. Ortega, and J. Plouet Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration and survival through integrin ligation FASEB J. 17 2003 1520 1522
115. P. Carmeliet, M.G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, and F. Bono Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis Cell 98 1999 147 157
116. K. Pajusola, O. Aprelikova, G. Pelicci, H. Weich, L. Claesson-Welsh, and K. Alitalo Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors Oncogene 9 1994 3545 3555
117. J. Lee, A. Gray, J. Yuan, S.-M. Louth, H. Avraham, and W. Wood Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 Proc. Natl. Acad. Sci. U. S. A. 93 1996 1988 1992
118. D.C. Hughes Alternative splicing of the human VEGFGR-3/FLT4 gene as a consequence of an integrated human endogenous retrovirus J. Mol. Evol. 53 2001 77 79
119. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, and E. Kukk A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and Kdr (VEGFR-2) receptor tyrosine kinases EMBO J. 15 1996 290 298
120. M.G. Achen, M. Jeltsch, E. Kukk, T. Makinen, A. Vitali, and A.F. Wilks Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc. Natl. Acad. Sci. U. S. A. 95 1998 548 553
121. A. Kaipainen, J. Korhonen, T. Mustonen, V.M. van Hinsbergh, G.-H. Fang, and D. Dumont Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development Proc. Natl. Acad. Sci. U. S. A. 92 1995 3566 3570
122. T. Partanen, J. Arola, A. Saaristo, L. Jussila, A. Ora, and M. Miettinen VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues FASEB J. 14 2000 2087 2096
123. M. Skobe, L.M. Hamberg, T. Hawighorst, M. Shirner, G.L. Wolf, and K. Alitalo Concurrent induction of lymphangiogenesis, angiogenesis and macrophage recruitment by VEGF-C in melanoma Am. J. Pathol. 159 2001 893 903
124. T. Veikkola, M. Lohela, K. Ikenberg, T. Makinen, T. Korff, and A. Saaristo Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function FASEB J. 17 2003 2006 2013
125. D.J. Dumont, L. Jussila, J. Taipale, T. Mustonen, K. Pajusola, and M. Breitman Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 Science 282 1998 946 949
126. K. Hamada, Y. Oike, N. Takakura, Y. Ito, L. Jussila, and D.J. Dumont VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis Blood 96 2000 3793 3800
127. T. Makinen, L. Jussila, T. Veikkola, T. Karpanen, M.I. Kettunen, and K.J. Pulkkanen Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 Nat. Med. 7 2001 199 205
128. A. Irrthum, M.J. Karkkainen, K. Devriendt, K. Alitalo, and M. Vikkula Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase Am. J. Hum. Genet. 67 2000 295 301
129. M.J. Karkkainen, R.E. Ferrell, E.C. Lawrence, M.A. Kimak, K.L. Levinson, and M.A. McTigue Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema Nat. Genet. 25 2000 153 159
130. M.J. Karkkainen, A. Saaristo, L. Jussila, K.A. Karila, E.C. Lawrence, and K. Pajusola A model for gene therapy of human hereditary lymphedema Proc. Natl. Acad. Sci. U. S. A. 98 2001 12677 12682
131. L. Chen, P. Hamrah, C. Cursiefen, Q. Zhang, B. Pytowski, and J.W. Streilein Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity Nat. Med. 10 2004 13 15
132. M. Klagsbrun, S. Takashima, and R. Mamluk The role of neuropilin in vascular and tumor biology Adv. Exp. Med. Biol. 515 2002 33 48
133. A. Bagri, and M. Tessier-Lavigne Neuropilins as semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance Adv. Exp. Med. Biol. 515 2002 13 31
134. T. Kawasaki, Y. Bekku, F. Suto, T. Kitsukawa, M. Taniguchi, and I. Nagatsu Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system Development 129 2002 671 680
135. M. Klagsbrun, J. Folkman, Angiogenesis. In: Sporn, M.B. Roberts, A.B., editors. Peptide growth factors and their receptors. Springer-Verlag, New York: Springer-Verlag, M Klagsbrun, Folkman J 1991, p. 549-86.
136. T. Kitsukawa, A. Shimono, A. Kawakami, H. Kondoh, and F. Hajime Over expression of a membrane protein, neuropilin, in chimeric mice causes anomalities in the cardiovascular system, nervous system and limbs Development 121 1995 4309 4318
137. Y. Herzog, C. Kalcheim, N. Kahane, R. Reshef, and G. Neufeld Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins Mech. Dev. 109 2001 115 119
138. L. Yuan, D. Moyon, L. Pardanaud, C. Breant, M.J. Karkkainen, and K. Alitalo Abnormal lymphatic vessel development in neuropilin 2 mutant mice Development 129 2002 4797 4806
139. T. Kawasaki, T. Kitsukawa, Y. Bekku, Y. Matsuda, M. Sanbo, and T. Yagi A requirement for neuropilin-1 in embryonic vessel formation Development 126 1999 4895 4902
140. C. Gu, E.R. Rodriguez, D.V. Reimert, T. Shu, B. Fritzsch, and L.J. Richards Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development Dev. Cell 5 2003 45 57
141. S. Takashima, M. Kitakaze, M. Asakura, H. Asanuma, S. Sanada, and F. Tashiro Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis Proc. Natl. Acad. Sci. U. S. A. 99 2002 3657 3662
142. S. Yla-Herttuala, and K. Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat. Med. 9 2003 694 701
143. D. Scholz, W.J. Cai, and W. Schaper Arteriogenesis, a new concept of vascular adaptation in occlusive disease Angiogenesis 4 2001 247 257
144. T.K. Rosengart, S.R. Patel, and R.G. Crystal Therapeutic angiogenesis: protein and gene therapy delivery strategies J. Cardiovasc. Risk 6 1999 29 40
145. S.B. Freedman, P. Vale, C. Kalka, M. Kearney, A. Pieczek, and J. Symes Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA Hum. Gene Ther. 13 2002 1595 1603
146. I. Baumgartner, and J.M. Isner Gene therapy for peripheral vascular disease Israel Med. Assoc. J. 2 2000 27 32
147. S. Rajagopalan, ERr Mohler, R.J. Lederman, F.O. Mendelsohn, J.F. Saucedo, and C.K. Goldman Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication Circulation 108 2003 1933 1938
148. P. Carmeliet VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6 2000 1102 1103
149. K. Sueishi, Y. Yonemitsu, K. Nakagawa, Y. Kaneda, M. Kumamoto, and Y. Nakashima Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor Ann. N. Y. Acad Sci. 811 1997 311 324
150. M.R. Hayden, and S.C. Tyagi Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation Cardiovasc. Diabetol. 3 2004 1
151. L. Salomonsson, S. Pettersson, M.C. Englund, O. Wiklund, and B.G. Ohlsson Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages Eur. J. Clin. Invest. 32 2002 767 774
152. K. Nakagawa, Y.X. Chen, H. Ishibashi, Y. Yonemitsu, T. Murata, and Y. Hata Angiogenesis and its regulation: roles of vascular endothelial cell growth factor Semin. Thromb. Hemost. 26 2000 61 66
153. F.L. Celletti, J.M. Waugh, P.G. Amabile, A. Brendolan, P.R. Hilfiker, and M.D. Dake Vascular endothelial growth factor enhances atherosclerotic plaque progression Nat. Med. 7 2001 425 429
154. K.S. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, and E. Sylvin Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 100 2003 4736 4741
155. K.B. Lemstrom, R. Krebs, A.I. Nykanen, J.M. Tikkanen, R.K. Sihvola, and E.M. Aaltola Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis Circulation 105 2002 2524 2530
156. C.H. Cho, R.A. Kammerer, H.J. Lee, K. Yasunaga, K.T. Kim, and H.H. Choi Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis Proc. Natl. Acad. Sci. U. S. A. 101 2004 5553 5558
157. S. Rafii, and D. Lyden Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 9 2003 702 712
158. S.M. Majka, K.A. Jackson, K.A. Kienstra, M.W. Majesky, M.A. Goodell, and K.K. Hirschi Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration J. Clin. Invest. 111 2003 71 79
159. A.J. Wagers, R.I. Sherwood, J.L. Christensen, and I.L. Weissman Little evidence for developmental plasticity of adult hematopoietic stem cells Science 297 2002 2256 2259
160. T. Ziegelhoeffer, B. Fernandez, S. Kostin, M. Heil, R. Voswinckel, and A. Helisch Bone marrow-derived cells do not incorporate into the adult growing vasculature Circ. Res. 94 2004 230 238
161. I. Rajantie, M. Ilmonen, A. Alminaite, U. Ozerden, K. Alitalo, and P. Salven Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells Blood 104 2004 2084 2086
162. R.K. Jain Molecular regulation of vessel maturation Nat. Med. 9 2003 685 693
163. E. Ruoslahti Vascular zip codes in angiogenesis and metastasis Biochem. Soc. Trans. 32 2004 397 402
164. J.C. Yang, L. Haworth, R.M. Sherry, P. Hwu, D.J. Schwartzentruber, and S.L. Topalian A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer New Engl. J. Med. 349 2003 427 434
165. J.W. Bainbridge, A.R. Mistry, A.J. Thrasher, and R.R. Ali Gene therapy for ocular angiogenesis Clin. Sci. 104 2003 561 575
166. L.P. Aiello, E.A. Pierce, E.D. Foley, H. Takagi, H. Chen, and L. Riddle Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins Proc. Natl. Acad. Sci. U. S. A. 92 1995 10457 10461
167. G.S. Robinson, E.A. Pierce, S.L. Rook, E. Foley, R. Webb, and L.E.S. Smith Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy Proc. Natl. Acad. Sci. U. S. A. 93 1996 4851 4856
168. H. Ozaki, M.S. Seo, K. Ozaki, H. Yamada, E. Yamada, and N. Okamoto Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am. J. Pathol. 156 2000 697 707
169. S. Ishida, T. Usui, K. Yamashiro, Y. Kaji, S. Amano, and Y. Ogura VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization J. Exp. Med. 198 2003 483 489
170. M. Detmar Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis J. Invest. Dermatol. 122 2004 xiv-v
171. L.P. Reynolds, A.T. Grazul-Bilska, and D.A. Redmer Angiogenesis in the female reproductive organs: pathological implications Int. J. Exp. Pathol. 83 2003 151 163
172. S.G. Rockson Lymphedema Am. J. Med. 110 2001 288 295
173. K.A. Northup, M.H. Witte, and C.L. Witte Syndromic classification of hereditary lymphedema Lymphology 36 2003 162 189
174. J. Fang, S.L. Dagenais, R.P. Erickson, M.F. Arlt, M.W. Glynn, and J.L. Gorski Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome Am. J. Hum. Genet. 67 2000 1382 1388
175. T.V. Petrova, T. Karpanen, C. Norrmen, R. Mellor, T. Tamakoshi, and D. Finegold Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis Nat. Med. 10 2004 974 981
176. T.P. Padera, A. Kadambi, E. di Tomaso, C.M. Carreira, E.B. Brown, and Y. Boucher Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 2002 1883 1886
177. M.G. Achen, R.A. Williams, M.E. Baldwin, P. Lai, S. Roufail, and K. Alitalo The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer Growth Factors 20 2002 99 107
178. S.M. Maula, M. Luukkaa, R. Grenman, D. Jackson, S. Jalkanen, and R. Ristamaki Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region Cancer Res. 63 2003 1920 1926
179. S.S. Dadras, T. Paul, J. Bertoncini, L.F. Brown, A. Muzikansky, and D.G. Jackson Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival Am. J. Pathol. 162 2003 1951 1960
180. O. Straume, D.G. Jackson, and L.A. Akslen Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma Clin. Cancer Res. 9 2003 250 256